Report Detail

Request for Sample of this report

Pharma & Healthcare Global Gene Delivery or Gene Therapy Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4652836
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 108 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gene Delivery or Gene Therapy Drug market size was valued at US$ 14080 million in 2024 and is forecast to a readjusted size of USD 48880 million by 2031 with a CAGR of 19.7% during review period.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
This report is a detailed and comprehensive analysis for global Gene Delivery or Gene Therapy Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene Delivery or Gene Therapy Drug market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gene Delivery or Gene Therapy Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gene Delivery or Gene Therapy Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gene Delivery or Gene Therapy Drug market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Delivery or Gene Therapy Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Delivery or Gene Therapy Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene Delivery or Gene Therapy Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Market segment by Application
Neurological Diseases
Cancer
Other
Market segment by players, this report covers
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Delivery or Gene Therapy Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Delivery or Gene Therapy Drug, with revenue, gross margin, and global market share of Gene Delivery or Gene Therapy Drug from 2020 to 2025.
Chapter 3, the Gene Delivery or Gene Therapy Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gene Delivery or Gene Therapy Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Delivery or Gene Therapy Drug.
Chapter 13, to describe Gene Delivery or Gene Therapy Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Gene Delivery or Gene Therapy Drug by Type
    • 1.3.1 Overview: Global Gene Delivery or Gene Therapy Drug Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Gene Delivery or Gene Therapy Drug Consumption Value Market Share by Type in 2024
    • 1.3.3 Viral Gene Delivery System
    • 1.3.4 Non-viral Gene Delivery System
  • 1.4 Global Gene Delivery or Gene Therapy Drug Market by Application
    • 1.4.1 Overview: Global Gene Delivery or Gene Therapy Drug Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Neurological Diseases
    • 1.4.3 Cancer
    • 1.4.4 Other
  • 1.5 Global Gene Delivery or Gene Therapy Drug Market Size & Forecast
  • 1.6 Global Gene Delivery or Gene Therapy Drug Market Size and Forecast by Region
    • 1.6.1 Global Gene Delivery or Gene Therapy Drug Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Gene Delivery or Gene Therapy Drug Market Size by Region, (2020-2031)
    • 1.6.3 North America Gene Delivery or Gene Therapy Drug Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Gene Delivery or Gene Therapy Drug Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Gene Delivery or Gene Therapy Drug Market Size and Prospect (2020-2031)
    • 1.6.6 South America Gene Delivery or Gene Therapy Drug Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Gene Delivery or Gene Therapy Drug Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Biogen
    • 2.1.1 Biogen Details
    • 2.1.2 Biogen Major Business
    • 2.1.3 Biogen Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.1.4 Biogen Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Biogen Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.2.4 Novartis Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Gilead Sciences
    • 2.3.1 Gilead Sciences Details
    • 2.3.2 Gilead Sciences Major Business
    • 2.3.3 Gilead Sciences Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.3.4 Gilead Sciences Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Gilead Sciences Recent Developments and Future Plans
  • 2.4 Sarepta Therapeutics
    • 2.4.1 Sarepta Therapeutics Details
    • 2.4.2 Sarepta Therapeutics Major Business
    • 2.4.3 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.4.4 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
  • 2.5 Alnylam Pharmaceuticals
    • 2.5.1 Alnylam Pharmaceuticals Details
    • 2.5.2 Alnylam Pharmaceuticals Major Business
    • 2.5.3 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.5.4 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
  • 2.6 Amgen
    • 2.6.1 Amgen Details
    • 2.6.2 Amgen Major Business
    • 2.6.3 Amgen Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.6.4 Amgen Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Amgen Recent Developments and Future Plans
  • 2.7 Spark Therapeutics
    • 2.7.1 Spark Therapeutics Details
    • 2.7.2 Spark Therapeutics Major Business
    • 2.7.3 Spark Therapeutics Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.7.4 Spark Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Spark Therapeutics Recent Developments and Future Plans
  • 2.8 Akcea Therapeutics
    • 2.8.1 Akcea Therapeutics Details
    • 2.8.2 Akcea Therapeutics Major Business
    • 2.8.3 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.8.4 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Akcea Therapeutics Recent Developments and Future Plans
  • 2.9 Sunway Biotech
    • 2.9.1 Sunway Biotech Details
    • 2.9.2 Sunway Biotech Major Business
    • 2.9.3 Sunway Biotech Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.9.4 Sunway Biotech Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Sunway Biotech Recent Developments and Future Plans
  • 2.10 SIBIONO
    • 2.10.1 SIBIONO Details
    • 2.10.2 SIBIONO Major Business
    • 2.10.3 SIBIONO Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.10.4 SIBIONO Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 SIBIONO Recent Developments and Future Plans
  • 2.11 AnGes
    • 2.11.1 AnGes Details
    • 2.11.2 AnGes Major Business
    • 2.11.3 AnGes Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.11.4 AnGes Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 AnGes Recent Developments and Future Plans
  • 2.12 Orchard Therapeutics
    • 2.12.1 Orchard Therapeutics Details
    • 2.12.2 Orchard Therapeutics Major Business
    • 2.12.3 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.12.4 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Orchard Therapeutics Recent Developments and Future Plans
  • 2.13 Human Stem Cells Institute
    • 2.13.1 Human Stem Cells Institute Details
    • 2.13.2 Human Stem Cells Institute Major Business
    • 2.13.3 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Product and Solutions
    • 2.13.4 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Human Stem Cells Institute Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Gene Delivery or Gene Therapy Drug Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Gene Delivery or Gene Therapy Drug by Company Revenue
    • 3.2.2 Top 3 Gene Delivery or Gene Therapy Drug Players Market Share in 2024
    • 3.2.3 Top 6 Gene Delivery or Gene Therapy Drug Players Market Share in 2024
  • 3.3 Gene Delivery or Gene Therapy Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Gene Delivery or Gene Therapy Drug Market: Region Footprint
    • 3.3.2 Gene Delivery or Gene Therapy Drug Market: Company Product Type Footprint
    • 3.3.3 Gene Delivery or Gene Therapy Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Gene Delivery or Gene Therapy Drug Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Gene Delivery or Gene Therapy Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Gene Delivery or Gene Therapy Drug Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Gene Delivery or Gene Therapy Drug Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Gene Delivery or Gene Therapy Drug Consumption Value by Type (2020-2031)
  • 6.2 North America Gene Delivery or Gene Therapy Drug Market Size by Application (2020-2031)
  • 6.3 North America Gene Delivery or Gene Therapy Drug Market Size by Country
    • 6.3.1 North America Gene Delivery or Gene Therapy Drug Consumption Value by Country (2020-2031)
    • 6.3.2 United States Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Gene Delivery or Gene Therapy Drug Consumption Value by Type (2020-2031)
  • 7.2 Europe Gene Delivery or Gene Therapy Drug Consumption Value by Application (2020-2031)
  • 7.3 Europe Gene Delivery or Gene Therapy Drug Market Size by Country
    • 7.3.1 Europe Gene Delivery or Gene Therapy Drug Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 7.3.3 France Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Delivery or Gene Therapy Drug Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Gene Delivery or Gene Therapy Drug Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Gene Delivery or Gene Therapy Drug Market Size by Region
    • 8.3.1 Asia-Pacific Gene Delivery or Gene Therapy Drug Consumption Value by Region (2020-2031)
    • 8.3.2 China Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.5 India Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Gene Delivery or Gene Therapy Drug Consumption Value by Type (2020-2031)
  • 9.2 South America Gene Delivery or Gene Therapy Drug Consumption Value by Application (2020-2031)
  • 9.3 South America Gene Delivery or Gene Therapy Drug Market Size by Country
    • 9.3.1 South America Gene Delivery or Gene Therapy Drug Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Delivery or Gene Therapy Drug Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Gene Delivery or Gene Therapy Drug Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Gene Delivery or Gene Therapy Drug Market Size by Country
    • 10.3.1 Middle East & Africa Gene Delivery or Gene Therapy Drug Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Gene Delivery or Gene Therapy Drug Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Gene Delivery or Gene Therapy Drug Market Drivers
  • 11.2 Gene Delivery or Gene Therapy Drug Market Restraints
  • 11.3 Gene Delivery or Gene Therapy Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Gene Delivery or Gene Therapy Drug Industry Chain
  • 12.2 Gene Delivery or Gene Therapy Drug Upstream Analysis
  • 12.3 Gene Delivery or Gene Therapy Drug Midstream Analysis
  • 12.4 Gene Delivery or Gene Therapy Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Gene Delivery or Gene Therapy Drug. Industry analysis & Market Report on Gene Delivery or Gene Therapy Drug is a syndicated market report, published as Global Gene Delivery or Gene Therapy Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Gene Delivery or Gene Therapy Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo